Skip to content
Menu

JP Morgan Maintains Overweight on IDEAYA Biosciences, Lowers Price Target to $55

Benzinga Newsdesk 11 hours ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight and lowers the price target from $62 to $55.

JP Morgan analyst Anupam Rama maintains IDEAYA Biosciences (NASDAQ:IDYA) with a Overweight and lowers the price target from $62 to $55.

Read at benzinga.com

← All stock news